Changes in dietary intake improve glycemic control following a structured nutrition therapy during Ramadan in individuals with type 2 diabetes

Yusof, Barakatun-Nisak Mohd; Hasbullah, Farah Yasmin; Shahar, Aainaa Syarfa Mohd; Omar, Noraida; Zaid, Zalina Abu; Mukhtar, Firdaus; Liu, Rachel Xin Yi; Marczewska, Agnieszka; Hamdy, Osama

doi:10.1016/j.clnesp.2021.09.738

Cited by 6 publications

(5 citation statements)

References 35 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The common mechanism by which dietary quality and depression affect patients' glycaemic control may be insulin resistance. It has been reported that patients with imbalanced dietary intake have increased in ammatory indices in their bodies, leading to increased secretion of pro-in ammatory cytokines (e.g., tumour necrosis factor, interleukins), which activate the hypothalamic-pituitary-adrenal axis (HPA axis); the HPA axis prompted the adrenal glands to produce glucocorticoids, resulting in excessive cortisol secretion and increased insulin resistance (30). Elevated pro-in ammatory cytokines have become indicators of depression and can also increase insulin resistance through the above pathway when patients experience depression (31).…”

Section: Discussionmentioning

confidence: 99%

Interaction between dietary quality and depression on glycaemic control in type 2 diabetics

Jiang,

Lou,

et al. 2024

Preprint

View full text Add to dashboard Cite

Background Poorer diet quality and depression were both independent influences on poor glycaemic control in patients with type 2 diabetes (T2DM). The current study aimed to investigate the interaction between dietary quality and depression on blood sugar control in T2DM patients. Methods In the cross-sectional study, Participants were selected using a multistage cluster random method, and the Meal Frequency Questionnaire and the Patient Health Questionnaire-9 were respectively used to investigate 1088 patients' dietary quality and depression. Data of Physical measurement, glycated haemoglobin, and blood lipid detection were also collected. Results The rate of poor glycaemic control was 38.3% in patients with T2DM with poor dietary quality. After adjusting for other variables, the risk of poor glycaemic control in patients with T2DM with poor dietary quality and no depression was 2.04 times higher than that in patients with T2DM with good dietary quality and no depression; the risk of poor glycaemic control in patients with T2DM with poor dietary quality and no depression was 1.96 times higher than that in patients with T2DM with good dietary quality and no depression; when poor dietary quality and depression co-existed, patients with T2DM with poor dietary quality and depression were at greater risk for poor glycaemic control. Conclusion The study revealed that in individuals with T2DM, there was a significant additive interaction between poor dietary quality and depressive symptoms, exacerbating poor glycaemic control. This synergistic effect suggested that concurrent management of dietary habits and mental health is crucial for optimizing glycaemic outcomes in this population.

show abstract

Section: Discussionmentioning

confidence: 99%

Interaction between dietary quality and depression on glycaemic control in type 2 diabetics

Jiang,

Lou,

et al. 2024

Preprint

View full text Add to dashboard Cite

show abstract

“…In a separate RCT by Mottalib et al, overweight and obese adults with T2D undergoing structured nutrition therapy with a DSF (1–3 times daily for 4 months) experienced significant HbA1c reductions of −0.61% and − 0.66%, with and without weekly tele-counselling by a nutritionist, respectively, compared with a 0.06% increase in the control group with individualized nutrition therapy (regular meal planned with the study nutritionist) ( 30 ). Another RCT comparing structured Ramadan Nutrition Therapy with a DSF versus SOC in individuals with T2D showed that after 8 weeks of intervention, the DSF group had improved glycemic control (HbA1c and fasting plasma glucose) and enhanced dietary adequacy ( 42 ). In a few RCTs where DSFs were used as meal replacement or partial meal replacement as a component of lifestyle intervention ( 31 , 32 , 35 ), HbA1c changes from baseline ranged from −0.5% to −1.1%.…”

Section: Discussionmentioning

confidence: 99%

“…Participants in the highest quartile of meal replacement use (608 meal replacements in 1 year) were 4.0 times more likely to reach the 7% weight loss goal and 4.1 times more likely to reach the 10% goal than participants in the lowest quartile (117 meal replacements in 1 year) ( 52 , 53 ). A study that compared structured Ramadan Nutrition Therapy with a DSF versus SOC in individuals with T2D for 8 weeks showed that with each 1% increase in adherence to the DSF, there was a corresponding reduction of 0.01% in HbA1c levels ( 42 ).…”

Section: Discussionmentioning

confidence: 99%

“…The risk of insulin resistance varies between Asian and Western populations, with the former being more prone to visceral adiposity, in addition to beta-cell dysfunction ( 41 ). Some Asian studies of DSF intervention have been reported, but small sample sizes and non-randomized design make it difficult to draw definitive conclusions ( 29 , 32 , 37 , 42 ).…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Diabetes-specific formula with standard of care improves glycemic control, body composition, and cardiometabolic risk factors in overweight and obese adults with type 2 diabetes: results from a randomized controlled trial

Tey,

Chee,

Deerochanawong

et al. 2024

Front. Nutr.

View full text Add to dashboard Cite

Background and aimsMedical nutrition therapy is important for diabetes management. This randomized controlled trial investigated the effects of a diabetes-specific formula (DSF) on glycemic control and cardiometabolic risk factors in adults with type 2 diabetes (T2D).MethodsParticipants (n = 235) were randomized to either DSF with standard of care (SOC) (DSF group; n = 117) or SOC only (control group; n = 118). The DSF group consumed one or two DSF servings daily as meal replacement or partial meal replacement. The assessments were done at baseline, on day 45, and on day 90.ResultsThere were significant reductions in glycated hemoglobin (−0.44% vs. –0.26%, p = 0.015, at day 45; −0.50% vs. −0.21%, p = 0.002, at day 90) and fasting blood glucose (−0.14 mmol/L vs. +0.32 mmol/L, p = 0.036, at day 90), as well as twofold greater weight loss (−1.30 kg vs. –0.61 kg, p < 0.001, at day 45; −1.74 kg vs. –0.76 kg, p < 0.001, at day 90) in the DSF group compared with the control group. The decrease in percent body fat and increase in percent fat-free mass at day 90 in the DSF group were almost twice that of the control group (1.44% vs. 0.79%, p = 0.047). In addition, the percent change in visceral adipose tissue at day 90 in the DSF group was several-fold lower than in the control group (−6.52% vs. –0.95%, p < 0.001). The DSF group also showed smaller waist and hip circumferences, and lower diastolic blood pressure than the control group (all overall p ≤ 0.045).ConclusionDSF with SOC yielded significantly greater improvements than only SOC in glycemic control, body composition, and cardiometabolic risk factors in adults with T2D.

show abstract

“…The impact of dietary modifications during Ramadan and its potential influence on glycemic control in diabetes were the subjects of two original articles and one review. First, Mohd Yusof et al 12 assessed dietary intake following structured Ramadan nutrition therapy and determined the association between changes in dietary intake and glycemic control parameters in patients with T2DM. This was done in an 8-week, parallel group, nonrandomized study of 60 T2DM patients who had structured Ramadan nutrition therapy (sRNT; n = 38) or standard care (SC; n = 22) group.…”

Section: Highlights Of the Literaturementioning

confidence: 99%

Ramadan Fasting and Diabetes (2021): The Year in Review

Beshyah

Hafidh

Kenz

et al. 2022

Journal of Diabetes and Endocrine Practice

View full text Add to dashboard Cite

Introduction The literature on the impact of Ramadan fasting (RF) on diabetes is widely spread in many journals. This makes it not readily accessible to those interested in the subject. We aimed to provide a narrative overview of the global literature production in 1 year (2021) on diabetes and RF. Materials and Methods This was a narrative, nonsystematic review of the international literature from a single major medical online database (i.e., PubMed) during the year 2021. The search term “Ramadan fasting AND Diabetes” was used, and the relevant literature was narrated in a concise thematic account. Results The publications spanned a vast array of topics related to diabetes and RF, including epidemiology, assessments of safety and efficacy profiles of older and newer diabetes therapies, hypoglycemia, diabetes education, use of advanced technology for the treatment, and monitoring and impact on pregnancy. Some reports covered the interaction of Ramadan and the novel coronavirus disease 2019 (COVID-19) in relationship to diabetes. Professional concerns, patients' perspectives, and telemedicine's role in RF were also addressed. Conclusion The current narration presents this year's literature on the safety of fasting practices, care models, and patients' experiences and perspectives. Work should continue on comprehensive assessments for the interplay of diabetes and RF under different settings. Particular attention should focus on the roles of newer antidiabetic medicines and advanced technology for safer fasting practices.

show abstract

Changes in dietary intake improve glycemic control following a structured nutrition therapy during Ramadan in individuals with type 2 diabetes

Cited by 6 publications

References 35 publications

Interaction between dietary quality and depression on glycaemic control in type 2 diabetics

Interaction between dietary quality and depression on glycaemic control in type 2 diabetics

Diabetes-specific formula with standard of care improves glycemic control, body composition, and cardiometabolic risk factors in overweight and obese adults with type 2 diabetes: results from a randomized controlled trial

Ramadan Fasting and Diabetes (2021): The Year in Review

Contact Info

Product

Resources

About